Adverse reactions to psychedelics in naturalistic settings are associated with current psychopathology and well-being: A correlational study
Jaime Rojas-Hernández, Lucas F Borkel, Ángelo Santana Del Pino, Domingo Jesús Quintana Hernández, Luis Alberto Henríquez-Hernández
Psychiatry Research October 1, 2026 DOI: 10.1016/j.psychres.2026.117516 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cross-sectional survey Longitudinal Peer reviewed |
|---|---|
| Sample size | 1,022 |
| Population | People reporting naturalistic (non-clinical) psychedelic use who completed an online survey |
| Measures | Psychedelic Use Scale |
| Key findings | Acute adverse reactions were consistently associated with similar delayed reactions, and most acute reactions (except vomiting, which showed the opposite pattern) were associated with higher current psychopathology and lower well-being. Lifetime use of specific psychedelics and combined substances showed participant-level associations with particular adverse-reaction categories, and setting, companionship, motivations, younger age, and higher use frequency were also linked to reactions. The authors describe these as correlational, hypothesis-generating co-reporting patterns. |
Abstract
This study examines acute and delayed adverse reactions reported in naturalistic psychedelic use, focusing on their associations with substance-use patterns, contextual variables, and user motivations. Using an online survey incorporating the Psychedelic Use Scale, data were collected from a large naturalistic sample (N=1022) to analyze patterns of self-reported adverse reactions. Acute adverse reactions were consistently associated with similar delayed adverse reactions, suggesting continuity between immediate and subsequent self-reported adverse experiences. Furthermore, most acute adverse reactions, with the exception of vomiting, which showed an opposite pattern, were associated with higher current psychopathology and lower well-being. Self-reported lifetime use of individual psychedelics (e.g., DMT, MDMA, and LSD) and combined substances (e.g., alcohol, caffeine, and cannabis) showed participant-level associations with specific self-reported adverse-reaction categories, while MDMA use was also associated with poorer current psychological indicators. Adverse reactions were also associated with contextual variables, including setting, type of companionship, and user motivations. Younger age and higher current frequency of psychedelic consumption were associated with higher odds of reporting adverse reactions. Because the study is cross-sectional and retrospective, and adverse reactions were not linked to specific substances or psychedelic episodes, the findings should be interpreted as correlational, hypothesis-generating co-reporting patterns rather than as substance-specific attribution. Nevertheless, they provide an empirical basis for future prospective, longitudinal, and clinical studies aimed at clarifying temporal relationships and informing harm reduction strategies.
Citations in the library
Cites 21
- Psychedelics and Mental Health: A Population Study PLoS One August 19, 2013
- Adverse effects of psychedelics: From anecdotes and misinformation to systematic science. Journal of Psychopharmacology February 2, 2022
- Cessation and reduction in alcohol consumption and misuse after psychedelic use Journal of Psychopharmacology May 14, 2019
- Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects. ACS Pharmacology & Translational Science March 5, 2021
- Extended difficulties following the use of psychedelic drugs: A mixed methods study PLoS One October 24, 2023
and 16 more in the library